Menu

RNA Methylation Dynamics

Additions to the bases of RNA molecules can be written, read, and erased.

Jan 1, 2016
and Gidi Rechavi, Dan Dominissini, Chuan He

At least 140 alternative RNA nucleotide forms exist. On mRNA, the most common is the methylation of adenosine on the N6 position (m6A). This epigenetic mark is laid down by a “writer” protein complex that includes three well-characterized components: METTL3, METTL14, and WTAP. The reverse process of RNA demethylation is performed by “erasers,” such as the enzymes FTO and ALKBH5.

THE SCIENTIST STAFFRNA molecules marked with epigenetic modifications can then affect cellular processes through the function of specific “reader” proteins that bind the modified nucleotide. Known readers of m6A include YTHDF1, which stimulates protein synthesis by interacting with the translation machinery and increasing translation efficiency; human YTH domain family 2 (YTHDF2), which mediates mRNA degradation; and the RNA-binding protein heterogeneous nuclear ribonucleoprotein A2B1 (HNRNPA2B1), which mediates alternative splicing.

THE SCIENTIST STAFF

Read the full story.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.